Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx Group (MDXG) Operating Expenses: 2011-2025

Historic Operating Expenses for Mimedx Group (MDXG) over the last 15 years, with Sep 2025 value amounting to $72.7 million.

  • Mimedx Group's Operating Expenses rose 28.83% to $72.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $268.1 million, marking a year-over-year increase of 16.75%. This contributed to the annual value of $237.4 million for FY2024, which is 6.09% up from last year.
  • Latest data reveals that Mimedx Group reported Operating Expenses of $72.7 million as of Q3 2025, which was up 7.78% from $67.5 million recorded in Q2 2025.
  • In the past 5 years, Mimedx Group's Operating Expenses ranged from a high of $72.7 million in Q3 2025 and a low of $45.1 million during Q4 2022.
  • In the last 3 years, Mimedx Group's Operating Expenses had a median value of $58.0 million in 2024 and averaged $60.4 million.
  • Examining YoY changes over the last 5 years, Mimedx Group's Operating Expenses showed a top increase of 45.66% in 2021 and a maximum decrease of 10.40% in 2021.
  • Quarterly analysis of 5 years shows Mimedx Group's Operating Expenses stood at $46.7 million in 2021, then dropped by 3.45% to $45.1 million in 2022, then grew by 25.89% to $56.8 million in 2023, then increased by 13.79% to $64.6 million in 2024, then climbed by 28.83% to $72.7 million in 2025.
  • Its Operating Expenses stands at $72.7 million for Q3 2025, versus $67.5 million for Q2 2025 and $63.3 million for Q1 2025.